These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 9376591

  • 21. Generation of human natural killer cells from peripheral blood CD34+ cells mobilized by granulocyte colony-stimulating factor.
    Takenaka K, Mizuno SI, Harada M, Nagafuji K, Miyamoto T, Iwasaki H, Fujisaki T, Kubota A, Ohno Y, Arima F, Shigematsu H, Gondo H, Okamura T, Okamura S, Inaba S, Niho Y.
    Br J Haematol; 1996 Mar; 92(4):788-94. PubMed ID: 8616068
    [Abstract] [Full Text] [Related]

  • 22. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.
    Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N.
    Br J Haematol; 1994 Jul; 87(3):609-13. PubMed ID: 7527648
    [Abstract] [Full Text] [Related]

  • 23. Animal serum-free culture of purified human CD34+ cells: amplification of progenitors from G-CSF and GM-CSF-mobilized peripheral blood.
    Schain LR, Jain S, Wysocki M, Hall M, Dadey B, Pennathur-Das R, Biddle W, Wolf J, Okarma TB, Lebkowski JS.
    J Hematother; 1997 Aug; 6(4):335-49. PubMed ID: 9377072
    [Abstract] [Full Text] [Related]

  • 24. Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of alpha4 beta1 integrin expression and function.
    Prosper F, Stroncek D, McCarthy JB, Verfaillie CM.
    J Clin Invest; 1998 Jun 01; 101(11):2456-67. PubMed ID: 9616217
    [Abstract] [Full Text] [Related]

  • 25. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R, Murea S.
    Cytokines Mol Ther; 1995 Dec 01; 1(4):249-70. PubMed ID: 9384679
    [Abstract] [Full Text] [Related]

  • 26. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
    Litzow MR, Brashem-Stein C, Andrews RG, Bernstein ID.
    Blood; 1991 Jun 01; 77(11):2354-9. PubMed ID: 1710150
    [Abstract] [Full Text] [Related]

  • 27. Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15.
    Xiong Y, Mouginot M, Reppel L, Qian C, Stoltz JF, Bensoussan D, Decot V.
    Immunol Res; 2017 Dec 01; 65(6):1130-1138. PubMed ID: 29019081
    [Abstract] [Full Text] [Related]

  • 28. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
    Dreger P, Viehmann K, Steinmann J, Eckstein V, Müller-Ruchholtz W, Löffler H, Schmitz N.
    Exp Hematol; 1995 Feb 01; 23(2):147-54. PubMed ID: 7530212
    [Abstract] [Full Text] [Related]

  • 29. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
    Ho AD, Young D, Maruyama M, Corringham RE, Mason JR, Thompson P, Grenier K, Law P, Terstappen LW, Lane T.
    Exp Hematol; 1996 Nov 01; 24(13):1460-8. PubMed ID: 8950228
    [Abstract] [Full Text] [Related]

  • 30. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
    Maruyama K, Tsuji K, Tanaka R, Yamada K, Kodera Y, Nakahata T.
    Bone Marrow Transplant; 1998 Aug 01; 22(4):313-20. PubMed ID: 9722064
    [Abstract] [Full Text] [Related]

  • 31. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G, Fujiwara H, Rezvani K, Keyvanfar K, El Ouriaghli F, Grube M, Melenhorst J, Hensel N, Barrett AJ.
    J Leukoc Biol; 2004 Dec 01; 76(6):1214-9. PubMed ID: 15345723
    [Abstract] [Full Text] [Related]

  • 32. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D, Perrin M, Hoffmann S, Chang AE, Ratanatharathorn V, Uberti J, McDonagh KT, Mulé JJ.
    Clin Cancer Res; 1998 Nov 01; 4(11):2709-16. PubMed ID: 9829733
    [Abstract] [Full Text] [Related]

  • 33. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA.
    Bone Marrow Transplant; 1994 Dec 01; 14(6):877-84. PubMed ID: 7536069
    [Abstract] [Full Text] [Related]

  • 34. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L, Scambia G, Bonanno G, Coscarella A, De Santis R, Mele A, Battaglia A, Fattorossi A, Romeo V, Menichella G, Mancuso S, Leone G.
    Exp Hematol; 1999 Mar 01; 27(3):416-24. PubMed ID: 10089903
    [Abstract] [Full Text] [Related]

  • 35. Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation.
    Rambaldi A, Borleri G, Dotti G, Bellavita P, Amaru R, Biondi A, Barbui T.
    Blood; 1998 Mar 15; 91(6):2189-96. PubMed ID: 9490708
    [Abstract] [Full Text] [Related]

  • 36. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
    Janowska-Wieczorek A, Marquez LA, Nabholtz JM, Cabuhat ML, Montaño J, Chang H, Rozmus J, Russell JA, Edwards DR, Turner AR.
    Blood; 1999 May 15; 93(10):3379-90. PubMed ID: 10233890
    [Abstract] [Full Text] [Related]

  • 37. Analysis of peripheral blood CD34+ cells mobilized with granulocyte colony-stimulating factor (G-CSF) using a long-term culture system.
    Suzuki T, Muroi K, Amemiya Y, Miura Y.
    Bone Marrow Transplant; 1998 Apr 15; 21(8):751-7. PubMed ID: 9603397
    [Abstract] [Full Text] [Related]

  • 38. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.
    Tjønnfjord GE, Steen R, Evensen SA, Thorsby E, Egeland T.
    Blood; 1994 Oct 15; 84(8):2795-801. PubMed ID: 7522643
    [Abstract] [Full Text] [Related]

  • 39. A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study.
    Fruehauf S, Veldwijk MR, Seeger T, Schubert M, Laufs S, Topaly J, Wuchter P, Dillmann F, Eckstein V, Wenz F, Goldschmidt H, Ho AD, Calandra G.
    Cytotherapy; 2009 Oct 15; 11(8):992-1001. PubMed ID: 19929463
    [Abstract] [Full Text] [Related]

  • 40. Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients.
    Joshi SS, Miller K, Jackson JD, Warkentin P, Kessinger A.
    Cytotherapy; 2000 Oct 15; 2(1):15-24. PubMed ID: 12042051
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.